fludarabine has been researched along with Lymphocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thieblemont, C | 1 |
| Imagawa, J; Imamura, N; Katayama, Y; Kimura, A; Nimi, H; Simomura, T | 1 |
1 review(s) available for fludarabine and Lymphocytosis
| Article | Year |
|---|---|
Non-MALT marginal zone lymphomas.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antineoplastic Agents; beta 2-Microglobulin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Italy; L-Lactate Dehydrogenase; Lymph Nodes; Lymphocytosis; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prognosis; Splenectomy; Splenic Neoplasms; Survival Analysis; Vidarabine | 2008 |
1 other study(ies) available for fludarabine and Lymphocytosis
| Article | Year |
|---|---|
[Drug-resistant B cell chronic lymphocytic leukemia safely treated with rituximab to control leukemic cell increment and platelet transfusion dependence].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Drug Resistance, Neoplasm; Hepatomegaly; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphocytosis; Male; Middle Aged; Platelet Transfusion; Rituximab; Vidarabine | 2004 |